Multivisceral resections for rectal cancer

British Journal of Surgery

Volumn 99, Issue 8, 2012, Pages 1137-1143

  Smith, J D ^a   Nash, G M ^a   Weiser, M R ^a   Temple, L K ^a   Guillem, J G ^a   Paty, P B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; RECTUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME; VISCERA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POSTOPERATIVE COMPLICATIONS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VISCERA; YOUNG ADULT;

EID: 84863726792     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8820     Document Type: Article

References (15)

1. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK,. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 2010; 28: 264-271.
2. Harris DA, Davies M, Lucas MG, Drew P, Carr ND, Beynon J,; Swansea Pelvic Oncology Group. Multivisceral resection for primary locally advanced rectal carcinoma. Br J Surg 2011; 98: 582-588.
3. Chen YG, Liu YL, Jiang SX, Wang XS,. Adhesion pattern and prognosis studies of T4 N0 M0 colorectal cancer following en bloc multivisceral resection: evaluation of T4 subclassification. Cell Biochem Biophys 2011; 59: 1-6.
4. Ishiguro S, Akasu T, Fujita S, Yamamoto S, Kusters M, Moriya Y,. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery 2009; 145: 189-195.
5. Mathis KL, Nelson H, Pemberton JH,. Can unresectable colorectal cancer be cured? Adv Surg 2009; 43: 211-219.
6. Derici H, Unalp HR, Kamer E, Bozdag AD, Tansug T, Nazli O, et al., Multivisceral resections for locally advanced rectal cancer. Colorectal Dis 2008; 10: 453-459. (Pubitemid 351682172)
7. Vermaas M, Ferenschild FT, Verhoef C, Nuyttens JJ, Marinelli AW, Wiggers T, et al., Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol 2007; 33: 452-458. (Pubitemid 46586088)
8. Wiig JN, Poulsen JP, Larsen S, Braendengen M, Waehre H, Giercksky KE,. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer. Eur J Surg 2002; 168: 42-48. (Pubitemid 34293218)
9. Gebhardt C, Meyer W, Ruckriegel S, Meier U,. Multivisceral resection of advanced colorectal carcinoma. Langenbecks Arch Surg 1999; 384: 194-199. (Pubitemid 29227312)
10. Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C,. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg 2002; 235: 217-225. (Pubitemid 34111950)
11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, (eds). AJCC Cancer Staging Manual (7th edn). Springer: New York, 2010.
12. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, et al., Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 2008; 113: 57-64. (Pubitemid 351976386)
13. Carla Hajj MRW, McErlean A, Gollub M, Cercek A, Ding P-R, Saltz L, et al., Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer with and without synchronous resectable metastases. J Clin Oncol 2012; 30 (Suppl 4):abstract 599.
14. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al., Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674. (Pubitemid 46630432)
15. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, et al., Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 2009; 10: 1053-1062.